Product Information
TESTOSTERONE 12.5 MG/1.25 GRAM is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.8264 per GM under NDC 00832112142. Its NADAC has been published 620 times since Nov 19, 2014.
FDA first approved this application on Jun 4, 2014. Its Orange Book therapeutic-equivalence code is BX.
Strength
12.5 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832112142
Classification
Generic
Dosage Form
GEL, METERED
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204399FDA Approved
6/4/2014
TE Code
BX
On Market Since
6/16/2014
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has been published 620 times since Nov 19, 2014, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8264 per GM |
|---|---|
| All-time high | $2.0448 (Jan 13, 2016) |
| All-time low | $0.6126 (Jul 22, 2026) |
| 52-week high | $1.0033 |
| 52-week low | $0.6126 |
| Median price | $1.1667 |
| Average price | $1.2614 |
| Largest weekly change | +47.2% (Aug 21, 2024) |
| Weeks tracked | 620 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Testosterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE 12.5 MG/1.25 GRAM?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 12.5 MG/1.25 GRAM, manufactured by Upsher-Smith Laboratories LLC, is $0.8264 per GM (NDC 00832112142), effective Sep 30, 2026.
How has the price of TESTOSTERONE 12.5 MG/1.25 GRAM changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has declined 57.0%. It has been tracked across 620 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE 12.5 MG/1.25 GRAM?
Since Nov 19, 2014, the NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has ranged from a low of $0.6126 (Jul 22, 2026) to a high of $2.0448 (Jan 13, 2016), with a median of $1.1667 per GM.
Are there cheaper alternatives to TESTOSTERONE 12.5 MG/1.25 GRAM?
No other NADAC-published product currently shares the active ingredient and strength of TESTOSTERONE 12.5 MG/1.25 GRAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TESTOSTERONE 12.5 MG/1.25 GRAM?
TESTOSTERONE 12.5 MG/1.25 GRAM (NDC 00832112142) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.